Latest Breaking News On - Age therapeutics kurs - Page 1 : comparemela.com

18.10.2023 - Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to SAGE-718 for the . Seite 1

United statesLaura gaultSage therapeutics incDrug administrationOffice of orphan products developmentSage therapeuticsOrphan drug designationChief medical officerOrphan products developmentOrphan drug actSage therapeutics chartAge therapeutics kursAge therapeutics aktie